HUM-MOLGEN archive: HUM-MOLGEN News Alert

___________________________________________________________________________ IBC Life Sciences presents SCREENTECH(r) WORLD SUMMIT March 21-24, 2004 * Sheraton San Diego Hotel & Marina * San Diego, CA http://www.LifeSciencesInfo.com/ScreenTech?source=2866-64 ___________________________________________________________________________ INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS HUM-MOLGEN News Alert - February 03, 2004 - http://hum-molgen.org DIAGnostics - Clinical Research (professional requests) http://hum-molgen.org/clinical-research/ - 3q deletion http://hum-molgen.org/bb/Forum2/HTML/000164.html - Familial Cancer http://hum-molgen.org/bb/Forum2/HTML/000165.html - Post diagnostic request / call for collaboration http://hum-molgen.org/diagnostic-posting or contact hum-molgen@nic.surfnet.nl Genetic News by T.M. D'Souza, W. Kalle, A.W.I. Lo, R.V. Nemade, U. Sattler, F.S. Zollmann http://hum-molgen.org/NewsGen - Bringing Nerve Cells Together The initial formation of the synaptic connections that enable neurons to communicate with each other is a complex process, with newly formed synapses helping to direct how a dendrite will grow. http://hum-molgen.org/NewsGen/02-2004/msg08.html - Anti-Obesity Drugs Could Increase Risk Of Colorectal Cancer Compounds being developed into drugs to treat atherosclerosis and obesity may put patients at risk for colorectal cancer. http://hum-molgen.org/NewsGen/02-2004/msg07.html - Tumor Treatment Blocks Blood Vessels Scientists highlight the effects of bevacizumab (Avastin), an antibody that inactivates VEGF, on blood vessels in rectal tumors. http://hum-molgen.org/NewsGen/02-2004/msg06.html - Cerebral Malaria Often Misdiagnosed The findings in this study will be important for correctly identifying cerebral malaria patients for future clinical trials and have new implications for diagnosing cerebral malaria. http://hum-molgen.org/NewsGen/02-2004/msg05.html - Protecting Baby A systemic change occurs in the immune systems of pregnant women that lessens the possibility of fetal rejection as well as other potentially harmful autoimmune reactions. http://hum-molgen.org/NewsGen/02-2004/msg04.html - Down Syndrome Gene Helps Brain Cells Connect Every one of the trillion cells in the brain may have a unique identity, assigned by a gene called Dscam, and the same gene in humans has been implicated in Down syndrome. http://hum-molgen.org/NewsGen/02-2004/msg03.html - Complete Picture Of A Human Immune Pathway This snapshot of the hundreds of interactions involved provides the most complete and realistic picture to date of how this regulatory system functions, and identifies many potential targets for therapeutic intervention. http://hum-molgen.org/NewsGen/02-2004/msg02.html - Maternal Diet Affects Offspring Longevity In Mice This finding may have implications for pregnant and breast-feeding human mothers. http://hum-molgen.org/NewsGen/02-2004/msg01.html - Genetic Screening Recommended to Detect New Neurodegenerative Disorder in Men Over 50 Common and small mutation in the fragile X gene, once thought to have no health effects in male carriers, now linked to tremors, balance problems and memory deficits. http://hum-molgen.org/NewsGen/01-2004/msg20.html - New Method Identifies Human microRNA Targets Research into the mechanics of microRNAs, tiny molecules that can selectively silence genes, has revealed a new mode of gene regulation that scientists believe has a broad impact on both plant and animal cells. http://hum-molgen.org/NewsGen/01-2004/msg19.html - Low Free Testosterone Levels Linked to Alzheimer's Disease in Older Men Older men with lower levels of free testosterone circulating in their bloodstreams could be at higher risk of developing Alzheimer's disease http://hum-molgen.org/NewsGen/01-2004/msg18.html - Transgenic Animals Produced Using Cultured Sperm Study Opens New Possibilities for Biological Research, Gene Therapy http://hum-molgen.org/NewsGen/01-2004/msg17.html - First U.S. Tuberculosis Vaccine Trial in 60 Years Begins A new vaccine, made with several proteins from the bacterium that causes tuberculosis (TB), will soon enter the first phase of human safety testing. http://hum-molgen.org/NewsGen/01-2004/msg16.html - Gene Therapy in Salivary Glands Gene Therapy in Salivary Glands Could Lead to Promising Applications in Oral Diseases http://hum-molgen.org/NewsGen/01-2004/msg15.html - Perlegen Sciences and Galileo Genomics Form Collaboration to Determine the Genetic Basis of 21 Common Diseases Both companies announced a collaboration to rapidly develop a Quebec Linkage Disequilibrium Map (QLDM) consisting of approximately 40,000 SNPs chosen to represent the specific patterns of linkage disequilibrium in the Quebec Founder Population. http://hum-molgen.org/NewsGen/01-2004/msg14.html - Researchers develop computer application to 'read' medical literature The software, called IRIDESCENT, constructs a network of related objects starting with their co-occurrence within MEDLINE abstracts. http://hum-molgen.org/NewsGen/01-2004/msg13.html - European Virtual Institute for Genome Annotation The Commission of the European Union has awarded 12,000,000 Euro to 24 bioinformatics groups based in 14 countries throughout Europe to create a pan-European BioSapiens Network of Excellence in Bioinformatics. http://hum-molgen.org/NewsGen/01-2004/msg12.html - One dose of "designer" gene therapy may target specific body area Doctors may soon be able to inject gene therapy intravenously that travels to a specific part of the body. http://hum-molgen.org/NewsGen/01-2004/msg11.html - Contact Genetic News editors news@hum-molgen.org Literature http://hum-molgen.org/literature/ - Call For Papers - International Journal of Medical Sciences International Journal of Medical Sciences (ISSN 1449-1907) is a new journal launched in late 2003 publishing peer-reviewed scientific papers of significance in all areas of medical sciences from basic research to clinical and experimental work. http://hum-molgen.org/literature/01-2004/msg03.html Open Topic Forum - Human Cloning http://hum-molgen.org/bb/Forum9/HTML/000054.html Biomedical Positions http://hum-molgen.org/positions/ - Biotechnology: VP of Business Development The Kerber Group, Kirkland, 98034, USA http://hum-molgen.org/positions/non_academic_positions/1257.html - Cell and Molecular Biology / Anatomy: post doctoral fellow CNRS BioMarCell Resaerch team, Villefranche sur Mer http://hum-molgen.org/positions/postdocs/2371.html - Computational Genetics / Bioinformatics: Post Doctoral Associate Accelrys, San Diego, CA 92121 http://hum-molgen.org/positions/postdocs/2372.html - Medical Research (others): Research Teaching Specialist IV (Grant Funded) UMDNJ, PISCATAWAY, 08854, USA http://hum-molgen.org/positions/academic_positions/0129.html - Medical Research (others): Temporary Research Assistant UMDNJ, PISCATAWAY, 08854, USA http://hum-molgen.org/positions/academic_positions/0128.html - Medical Research (others): Senior Clinical Data Coordinators ICON Clinical Research, Inc., NORTH WALES, 19436, USA http://hum-molgen.org/positions/non_academic_positions/1253.html - Medical Research (others): Quality Management Specialist PROVIDENCE SAINT JOSEPH MEDICAL CENTER, BURBANK, 91501, USA http://hum-molgen.org/positions/non_academic_positions/1255.html - Medical Research (others): QA AUDITOR - PROJECT COMPLIANCE (GCP) PA 290358 ICON Clinical Research, Inc., NORTH WALES, 19436, USA http://hum-molgen.org/positions/non_academic_positions/1251.html - Others: Marketing Decision Sciences Analyst/ Consultant Rapp Collins Worldwide, New York, 10001, USA http://hum-molgen.org/positions/non_academic_positions/1259.html - Others: Quality Assurance Auditor, Project Compliance ICON Clinical Research, Inc., SAN FRANCISCO, 94101, USA http://hum-molgen.org/positions/non_academic_positions/1254.html - Others: 9 Post-Doctoral Research Fellows European Retinal Research Training Network [RETNET], 72070 Tuebingen, Germany http://hum-molgen.org/positions/postdocs/2370.html - Others: Manager, Medical Information - Massachusetts Work Wonders Staffing, LLC, Marlborough, MA http://hum-molgen.org/positions/non_academic_positions/1256.html - Others: SENIOR QUALITY ASSURANCE AUDITOR / MANAGER ICON Clinical Research, Inc., NORTH WALES, 19436, USA http://hum-molgen.org/positions/non_academic_positions/1252.html - Others: Business Development Associate - IVRS 290371 ICON Clinical Research, Inc., HOUSTON, 77001, USA http://hum-molgen.org/positions/non_academic_positions/1258.html - Pharmacology and Toxicology: Manager of Pharmacokinetics and Biopharmaceutics ICON Clinical Research, Inc., HANOVER, 21076, USA http://hum-molgen.org/positions/postdocs/2369.html - Write a position announcement (free) http://hum-molgen.org/cgi-bin/positions.pl?write0 Biomedical conferences http://hum-molgen.org/meetings/ Registry of Biomedical Companies (2071 entries) http://hum-molgen.org/companies/ Mailing List Administration (Join or leave the list) http://nic.surfnet.nl/scripts/wa.exe?SUBED1=hum-molgen&A=1 Feedback contact HUM-MOLGEN@nic.surfnet.nl Advertise at HUM-MOLGEN contact FS Zollmann (dialogue@hum-molgen.org) ___________________________________________________________________________ IBC Life Sciences presents SCREENTECH(r) WORLD SUMMIT March 21-24, 2004 * Sheraton San Diego Hotel & Marina * San Diego, CA http://www.LifeSciencesInfo.com/ScreenTech?source=2866-64 A Discovery and Development Conference and Exhibition featuring four in-depth scientific programs: - PROTEIN KINASES & PHOSPHATASES - PROTEASE INHIBITORS - NEURODEGENERATIVE DISEASES - HTS & ASSAY TECHNOLOGIES Create your own custom, niche programming ... This unique format of parallel conference programming will allow you to attend an in-depth program in your specific discipline, and increase your knowledge and contacts through joining in additional talks from any of the other program sessions. Plus, you will receive the documentation from all 4 programs at no additional charge! ___________________________________________________________________________ -- | INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS | HUM-MOLGEN - http://hum-molgen.org & hum-molgen@nic.surfnet.nl | (C) 1994-2004